
About BodyFast
BodyFast is a Healthcare company based in Munchen (Germany) founded in 2017. It operates as an intermittent fasting app for weight loss, personalized plans, and health tracking tools. It operates on a D2C and SaaS model. Its website bodyfast.app draws about 681 thousand monthly visits. BodyFast offers products and services including BodyFast App. Its focus areas include Health and Wellness, Fitness Tech, Weight Management and Intermittent Fasting. Its legal entity is BodyFast GmbH. Its competitors include Fastic, Fasti App, Fastpal, Women Who Fast and Apme and 1 more; 1 of its 6 listed competitors has raised funding.
Company details
BodyFast is a mobile application focused on intermittent fasting to help users lose weight and enhance health without strict diets. It provides personalized fasting plans, daily coaching, over 100 recipes, and tracking features for weight and water intake. Based in Germany, it serves millions of global users by promoting healthier eating habits through science-backed methods and motivational challenges.
- Headquarters Munchen, Germany
- SectorsHealthcare
- Website category Health · Nutrition Diets and Fitness
- Emailβ’β’β’β’β’β’β’β’
- Website bodyfast.app/en
- Legal Name Bodyfast Gmbh
Products & Services of BodyFast
BodyFast offers a comprehensive portfolio of products and services, including BodyFast App.
Mobile app for tracking intermittent fasting and personalized weight loss plans.
Apps and channels of BodyFast
BodyFast publishes 2 mobile apps with over 10M+ downloads.
Funding Insights of BodyFast
- Total Rounds 1
All 1 funding rounds of BodyFast with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2026 | – | Seed | β | β | β |
Timeline of BodyFast
2 dated milestones of BodyFast across 9 years, from founding to its latest funding, stage changes and deals.
- Founded BodyFast is founded.
- Funding First funding round.
Competitors of BodyFast
BodyFast has 6 listed competitors in our database, 1 of them funded. They include Fastic, Fasti App, Fastpal, Women Who Fast and Apme, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fastic.com | 2019 | Berlin, Germany | $5M | 23 | App for intermittent fasting management | |
| fastiapp.in | 2021 | Faridabad, India | – | – | Intermittent fasting app for natural weight loss and health improvement tracking. | |
| fastpal.app | 2023 | – | – | – | App for tracking intermittent fasting with timers and progress stats. | |
| womenwhofast.com | 2020 | Peculiar, United States | – | – | Offers a comprehensive intermittent fasting app designed specifically for women. | |
| apme.io | 2021 | Tallinn, Estonia | – | – | An application for intermittent fasting and dieting management is offered. | |
| lifetrons.ai | 2015 | Pune, India | – | – | Health tracking app with smart devices and personalized weight loss guidance. |
Detailed competitors of BodyFast
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BodyFast
The website of BodyFast (bodyfast.app) receives about 680.7K visits a month and ranks #184,929 among all websites worldwide, #503 in Nutrition Diets and Fitness.
- Monthly visits680.7K
▼ 6.7% vs previous month
- Unique visitors61.1K
per month
- Global rank#184,929
among all websites
- Category rank#503
Health · Nutrition Diets and Fitness
- Bounce rate44%
- Pages per visit9.0
- Average visit49 sec
- DevicesDesktop 9% Β· Mobile 91%
Websites whose visitors overlap most with BodyFast. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for BodyFast
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Obesity
10 companies that operate in the same segment as BodyFast (Obesity), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Satiety induction through digestable gastric balloon introduced via a swallowed capsule | 2009 | Wellesley, Massachusetts, United States | USD 174.04 M | USD 32.11 M | 137 | |
Therapeutics for diabetes and obesity treatment are developed. | 2005 | Lyon, Auvergne-rhone-alpes, France | USD 26 M | USD 1.74 M | 77 | |
Bioinformatics platform is provided for biomarkers and drug discovery. | 2015 | Vallejo, California, United States | USD 293.9 M | USD 8.99 M | 64 | |
Disease-modifying therapies for metabolic diseases are developed. | 2008 | Berkeley, California, United States | USD 385.52 M | – | – | |
Oral small molecule drugs for chronic diseases are developed. | 2017 | San Francisco, California, United States | USD 233 M | – | 163 | |
Small molecule therapeutics for obesity and metabolic disorders are developed. | 2017 | San Diego, California, United States | USD 138 M | – | 22 | |
Therapeutic devices for obesity and GI disorders are developed. | 2005 | Austin, Texas, United States | USD 80.36 M | USD 76.86 M | 132 | |
Nonsurgical endoscopic devices for GI tract anastomoses are developed. | 2012 | West Bridgewater, Massachusetts, United States | USD 91.98 M | – | 15 | |
Biopharmaceuticals for obesity and metabolic diseases are developed. | 2022 | New York, New York, United States | USD 505 M | – | 81 | |
Technology for oral delivery of large drug molecules is developed. | 2012 | San Jose, California, United States | USD 226.49 M | USD 1.63 M | 102 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BodyFast
BodyFast was founded in 2017 and raised its 1st funding round 9 years after it was founded.
BodyFast is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
BodyFast is a mobile application focused on intermittent fasting to help users lose weight and enhance health without strict diets. It provides personalized fasting plans, daily coaching, over 100 recipes, and tracking features for weight and water intake. Based in Germany, it serves millions of global users by promoting healthier eating habits through science-backed methods and motivational challenges.
BodyFast offers BodyFast App.
BodyFast operates through Bodyfast Gmbh.
Yes. BodyFast publishes BodyFast: Intermittent Fasting and 1 more app, with over 10 million downloads.
The website of BodyFast receives about 681 thousand visits a month and ranks #184,929 among all websites worldwide.